// App-Quantinova.ai

TCT-838 : Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index

Researchers

Presenter

  • Niklas Beyhoff

Principal Investigators

  • Davide Cao

  • Roxana Mehran

  • Moritz Blum

  • Samantha Sartori

  • Anastasios Roumeliotis

  • Ridhima Goel

  • Rishi Chandiramani

  • Asaad Khan

  • Prakash Krishnan

  • Nitin Barman

  • Usman Baber

  • George Dangas

  • Samin Sharma

  • Annapoorna Kini

Medical Centers

  • Mount Sinai Hospital, New York, New York

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA

  • Zena and Michael A. Weiner Cardiovascular Institute at Icahn School of Medicine at Mount Sinai, New York, New York

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • C reactive protein

  • Nucleoside diphosphate kinase A

  • High sensitivity C-reactive protein

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved